Literature DB >> 17661054

Encephalitis following Mycoplasma pneumonia (2007: 6b). Acute disseminated encephalomyelitis.

B Termote1, P Demaerel, G Wilms, B Dubois.   

Abstract

We report an unusual case concerning encephalitis following Mycoplasma pneumonia. This interpretation corner case showed an unusual pattern of lesion distribution, resembling primary nervous system angiitis. The distribution of the lesions according to the perivascular spaces suggests a predominant leptomeningeal infiltration.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17661054     DOI： 10.1007/s00330-006-0529-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN： 0938-7994            Impact factor:   5.315


  6 in total

Review 1.  Central nervous system manifestations of Mycoplasma pneumoniae infections.

Authors:  S Tsiodras; I Kelesidis; T Kelesidis; E Stamboulis; H Giamarellou
Journal:  J Infect       Date:  2005-09-19       Impact factor: 6.072

2.  Acute disseminated encephalomyelitis: MR and CT features.

Authors:  I Mader; K W Stock; T Ettlin; A Probst
Journal:  AJNR Am J Neuroradiol       Date:  1996-01       Impact factor: 3.825

3.  Gadolinium ring enhancement and mass effect in acute disseminated encephalomyelitis.

Authors:  C H van der Meyden; J F de Villiers; B D Middlecote; J Terblanchè
Journal:  Neuroradiology       Date:  1994-04       Impact factor: 2.804

4.  MRI in acute disseminated encephalomyelitis.

Authors:  K S Caldemeyer; R R Smith; T M Harris; M K Edwards
Journal:  Neuroradiology       Date:  1994-04       Impact factor: 2.804

5.  Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children.

Authors:  J L Hynson; A J Kornberg; L T Coleman; L Shield; A S Harvey; M J Kean
Journal:  Neurology       Date:  2001-05-22       Impact factor: 9.910

6.  Primary angiitis of the central nervous system: serial MRI of brain and spinal cord.

Authors:  A Campi; G Benndorf; M Filippi; P Reganati; V Martinelli; M R Terreni
Journal:  Neuroradiology       Date:  2001-08       Impact factor: 2.804
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.